Spondyloarthritis clinical trials

Explore recruiting spondyloarthritis clinical trials.

Recruiting spondyloarthritis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Spondyloarthritis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Study Participants with Active Axial Spondyloarthritis, Ankylosing Spondylitis, and Nonradiographic Axial Spondyloarthritis

Hungary, Poland, France, Belgium, Czechia, Spain +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)

Netherlands, Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 open-label imaging study to explore the effects of sonelokimab in patients with active axial spondyloarthritis

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Tofacitinib in early active axial spondyloarthritis: a prospective, randomized, double-blind, placebo-controlled multicentre study - FASTLANE

Germany, Bulgaria, Poland, Czechia

Therapeutic use (Phase IV) EU CTIS Study details

Direct comparison between NSAIDs and biosimilar TNFa blockers in patients with axial spondyloarthritis

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis (UP-FOR-U)

Spain, Poland, Netherlands, France, Bulgaria, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Spondyloarthritis trials by city

Spondyloarthritis in Toronto Spondyloarthritis in Vancouver Spondyloarthritis in Montreal Spondyloarthritis in Calgary Spondyloarthritis in Edmonton Spondyloarthritis in Ottawa Spondyloarthritis in Winnipeg Spondyloarthritis in Quebec City Spondyloarthritis in Hamilton Spondyloarthritis in Kitchener Spondyloarthritis in London Spondyloarthritis in Halifax Spondyloarthritis in New York Spondyloarthritis in Los Angeles Spondyloarthritis in Chicago Spondyloarthritis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease